FTO and leukemia: A recent report on targeting aberrant mRNA modification in leukemia has highlighted another potential therapeutic approach to suppress fat mass and obesity-associated protein (FTO), an RNA N6-methyladenosine (m6A) demethylase (Su et al., 2020).